Medicine by the Numbers

From The NNT Group, these provide short, concise, evidence-based ratings of therapies, diagnostic tests, and risk assessments commonly used in family medicine. These rating are based on patient-important benefits and harms.

Jun 1, 2017 Issue
Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C

May 1, 2017 Issue
Oral NSAIDs for Perineal Pain in the Early Postpartum Period

Apr 1, 2017 Issue
Vitamin E in Pregnancy

Mar 1, 2017 Issue
Buprenorphine Maintenance vs. Placebo for Opioid Dependence

Feb 1, 2017 Issue
Antiepileptic Drugs After First Unprovoked Seizure

Jan 1, 2017 Issue
Alpha-adrenergic Agonists for the Management of Opioid Withdrawal

Dec 1, 2016 Issue
Aripiprazole vs. Placebo or Haloperidol for Schizophrenia

Nov 1, 2016 Issue
Valproate for Adult Migraine Prophylaxis

Oct 1, 2016 Issue
Rivaroxaban vs. Warfarin for Anticoagulation in Patients with Atrial Fibrillation Undergoing Ablation and Cardioversion
Studies showed that 433 patients needed to be treated with rivaroxaban to prevent one stroke and 629 patients needed to be treated with rivaroxaban to prevent one thromboembolic event. Read more.

Sep 1, 2016 Issue
Perioperative Beta Blockers
Studies show that 1 in 72 patients had a nonfatal myocardial infarction prevents while harm end points included nonfatal stroke, hypotension, and bradycardia. Find out more.

Pages: 1 2 3 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now